Related Experiment Video
Updated: Jun 16, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Off-label drug use in a Pediatric Intensive Care Unit.
S B Bavdekar1, Pranjali A Sadawarte, Nithya J Gogtay
1Department of Pediatrics, Seth GS Medical College & KEM Hospital, Acharya Donde Road, Parel, Mumbai, India. drsbavdekar@vsnl.com
Indian Journal of Pediatrics
|January 22, 2010
Summary
Off-label drug use is common in Pediatric Intensive Care Units (PICUs), with over 70% of prescriptions being off-label. This practice spans all age groups and conditions, unaffected by illness severity.
Area of Science:
- Pediatric Pharmacology
- Critical Care Medicine
- Drug Utilization Studies
Background:
- Pediatric Intensive Care Units (PICUs) often manage critically ill children with complex conditions.
- Limited availability of evidence-based, approved medications for pediatric populations necessitates off-label drug use.
- Understanding the patterns of off-label prescribing is crucial for patient safety and optimizing pharmacotherapy in PICUs.
Purpose of the Study:
- To investigate the prevalence and characteristics of off-label medication use in a Pediatric Intensive Care Unit (PICU).
- To categorize the types of off-label prescribing (age, indication, dose, route, frequency).
- To explore potential associations between off-label drug use and patient factors like illness severity.
Main Methods:
- Prospective observational study conducted in a tertiary care Indian hospital.
- Data collected from 300 children admitted to the PICU over a six-month period.
- Prescriptions analyzed against the British National Formulary 2005 for off-label status, categorized by deviation from approved use.
Main Results:
- A total of 2237 prescriptions were analyzed, with 1579 (70.58%) identified as off-label.
- Off-label drug use was widespread across all age groups and systemic conditions.
- The extent of off-label prescribing was not significantly influenced by illness severity (multiple systems affected or need for ventilatory support).
Conclusions:
- Off-label drug use is highly prevalent in Pediatric Intensive Care Unit (PICU) settings.
- Commonly used medications in the PICU were frequently prescribed off-label.
- Further research and guidelines are needed to address the high rate of off-label prescribing in pediatric critical care.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...